About AGLOWMED LIMITED
AGLOWMED LIMITED is a Public Limited Company and was incorporated on Nov 07, 1983 in India. It is registered at Registrar of Companies, ROC Patna. Its registered address is 271, PATLIPUTRA COLONY, Patna, PATNA, Bihar, India, 800013. Its corporate identification number is (CIN) U24232BR1983PLC001901 and its current status is Active. Its industry classification as per MCA is manufacture Of Allopathic Pharmaceutical Preparations. It had a team size of 21 employees as on Aug 01, 2025.
AGLOWMED LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2025 as per records from Ministry of Corporate Affairs (MCA). AGLOWMED LIMITED's authorised share capital is ₹4.5Cr and its paid up capital is ₹2.96Cr. The current board of directors of AGLOWMED LIMITED comprises Ashok Sharma, Gyan Prakash and 4 more.
AGLOWMED LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025.
Key Metrics
CIN
U24232BR1983PLC001901
Location
Current Status
Active
Entity Type
Public Limited Company
Date Of Incorporation
Nov 07, 1983
Company Age
42 Years 8 Months
Registrar of Companies
ROC - Patna
Last AGM Date
Sep 30, 2025
Latest Revenue
₹100 - ₹500 Cr as on Mar 31, 2025
Latest Employee Count
21 as on Aug 01, 2025
Authorized Capital
₹4.5Cr
Paid Up Capital
₹2.96Cr
Contact Details for AGLOWMED LIMITED
- *****@aglowmed.com
- Registered Address
- 271, PATLIPUTRA COLONY, Patna, PATNA, Bihar, India, 800013
Brands associated with AGLOWMED LIMITED
There is one brand associated with AGLOWMED LIMITED which include Aglowmed .
Principal Business Activity of AGLOWMED LIMITED
The majority of AGLOWMED LIMITED's turnover comes from Manufacturing.
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | nfq |
Documents of AGLOWMED LIMITEDFY 25 Available
Filing Summary
Here is a summary of filing activity and document availability across financial years:
File Type | FY 24-25 | FY 23-24 | FY 22-23 | FY 21-22 | FY 20-21 |
|---|---|---|---|---|---|
Financial Statements | |||||
Annual Returns |
Latest Financials, Share Allotment and Annual Report
The latest filed financial documents, annual reports, and share allotment filings are shown below:
Recent Filings
Below are the most recent filings submitted by the company:
Document Name | Category | Filing Date |
|---|---|---|
Form CHG-1 | Charges | Jan 23, 2026 |
CERTIFICATE OF REGISTRATION OF CHARGE | Certificates | Jan 23, 2026 |
Optional Attachment-(1) | Charges | Jan 23, 2026 |
Instrument(s) of creation or modification of charge | Charges | Jan 23, 2026 |
Optional attachment(s)- if any | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
List of share holders, debenture holders; | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Photograph of the registered office of the Company showing external building and name prominently visible | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Form MGT-7 | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Form MGT-7 | Annual Returns and Balance Sheet eForms | Dec 29, 2025 |
Form AOC-4(XBRL) | Annual Returns and Balance Sheet eForms | Dec 24, 2025 |
To access all company documents and filings with a single purchase, Buy Financials and Company Filings FY 25 Available
Financials of AGLOWMED LIMITEDFY 25 Available
AGLOWMED LIMITED generated between ₹100 Cr and ₹500 Cr in revenue for the financial year ending on Mar 31, 2025. The revenue of AGLOWMED LIMITED has a compounded annual growth rate (CAGR) of 11% in the last 1 year.
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 7104 | 7388 | 8526 | 9718 | 4662 |
Total Sales | 2300 | 9010 | 3345 | 5519 | 5383 |
Total Expenses | 4082 | 5054 | 1128 | 1496 | 8907 |
Operating Expenses | 8178 | 6582 | 6750 | 7471 | 8809 |
Employee Expenses | 2535 | 9952 | 2369 | 7333 | 3567 |
Marketing Expenses | 7713 | 8078 | 2741 | 5785 | 1822 |
Operating Income (EBIT) | 3314 | 7609 | 7861 | 7069 | 8506 |
Interest Expenses | 4308 | 3381 | 7669 | 9982 | 7760 |
Expenses from other activities | 7013 | 1404 | 9062 | 1911 | 5554 |
EBITDA | 3752 | 7835 | 9326 | 5003 | 1971 |
Taxes | 3919 | 5825 | 3508 | 7470 | 6055 |
Net Profit | 4115 | 9483 | 4326 | 4204 | 8641 |
Balance Sheet | |||||
Assets | 5835 | 6201 | 8573 | 9950 | 6892 |
Accounts Receivables | 3850 | 3230 | 9042 | 2840 | 7027 |
Inventory | 9935 | 1515 | 1405 | 5866 | 9241 |
Liabilities | 8715 | 6018 | 5003 | 7933 | 1459 |
Total Debt | 5876 | 8230 | 9449 | 2153 | 9325 |
Accounts Payable | 7152 | 4249 | 3325 | 4935 | 4253 |
Equities | 1341 | 5063 | 7678 | 3679 | 2386 |
Cashflow Statement | |||||
Cash from Operating activities | 6223 | 2715 | 6301 | 7209 | 3776 |
Cash from Investing activities | 9040 | 8672 | 2947 | 4550 | 9163 |
Net cash from Financing activities | 2976 | 5573 | 7339 | 7751 | 2326 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 9499 | 7072 | 2024 | 8058 | 3681 |
EBIT Margin | 9640 | 1257 | 1374 | 4277 | 3812 |
Net Profit Margin | 1624 | 5777 | 1851 | 4575 | 6975 |
Return on Assets (ROA) | 4630 | 9852 | 7941 | 7527 | 9900 |
Return on Equity (ROE) | 9198 | 2270 | 3738 | 9565 | 5779 |
Return on Capital Employed | 4196 | 9404 | 5018 | 8539 | 3196 |
Return on Invested Capital | 1549 | 6295 | 3806 | 8873 | 3106 |
Efficiency Ratios | |||||
Asset Turnover | 5866 | 8254 | 2020 | 8423 | 1881 |
Receivables Turnover | 1297 | 7899 | 3745 | 2886 | 9694 |
Days Sales Outstanding | 1633 | 8452 | 5724 | 5211 | 2910 |
Inventory Turnover | 4876 | 3147 | 3256 | 9753 | 1873 |
Days Inventory Outstanding | 3580 | 7935 | 5042 | 9353 | 9674 |
Payables Turnover | 1348 | 7906 | 4160 | 6220 | 8753 |
Days Payables Outstanding | 2493 | 7282 | 9934 | 9356 | 9165 |
Liquidity Ratios | |||||
Current Ratio | 3697 | 5739 | 8395 | 3902 | 3448 |
Quick Ratio | 6265 | 9239 | 4426 | 9378 | 6838 |
Coverage Ratios | |||||
Cash Flow Coverage Ratio | 8109 | 7970 | 2802 | 6676 | 2068 |
Debt Ratios | |||||
Debt-to-Equity Ratio | 9606 | 6014 | 7323 | 5589 | 8694 |
Debt Ratio | 1494 | 6819 | 8427 | 5822 | 3354 |
Interest Coverage Ratio | 3947 | 8775 | 5945 | 3218 | 8838 |
Debt Service Coverage Ratio | 5686 | 1572 | 8568 | 7018 | 6021 |
Net Debt/EBITDA | 4536 | 9885 | 3077 | 5484 | 7554 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 4211 | 1050 | 6744 | 6491 | 3122 |
Earnings Growth Rate (CAGR) | 2577 | 5584 | 8454 | 7751 | 3169 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
Compounded Annual Growth Rate of AGLOWMED LIMITED
Revenue CAGR | Growth |
|---|---|
1 Year | 11% |
3 Year | 864 |
5 Year | 201 |
EBITDA CAGR | Growth |
|---|---|
1 Year | 6% |
3 Year | 778 |
5 Year | 852 |
MSME Payment Delays by AGLOWMED LIMITED
Loans and Charges on AGLOWMED LIMITED
AGLOWMED LIMITED
has taken 44 loans.
Here is a list of loans and charges on AGLOWMED LIMITED:
As a Borrower
Loan/ Charge ID | Lender Name | Loan Amount | Status | Creation Date | Closure Date |
|---|---|---|---|---|---|
101228139 | ₹2Cr | vbiqaay | Jan 01, 2026 | qaiyeoo | |
101185120 | ₹22.6L | xzg{oiw | Oct 24, 2025 | basgsau | |
100925086 | ₹1.19Cr | ut{pebf | Jan 29, 2024 | wtjygsx | |
100585698 | - | ₹12Cr | telanlx | Apr 30, 2022 | ehyiphj |
100397630 | - | ₹3.75Cr | ctidbpa | Jul 16, 2020 | eolc{ax |
100261894 | ₹5.33Cr | wganglb | May 14, 2019 | lpb{xsv | |
100222238 | - | ₹10Cr | fzxbisz | Sep 29, 2018 | ncdzmrx |
100219589 | - | ₹9.5Cr | wfxufzx | Sep 28, 2018 | bl{evlc |
100165116 | - | ₹8.44L | xkyhbyq | Jan 31, 2018 | prrxfss |
100148552 | - | ₹14.1L | oz{zoop | Dec 12, 2017 | cpdhqfh |
100113562 | - | ₹12L | ffbmvra | Jun 29, 2017 | orvyeyb |
100104835 | - | ₹8.87L | cqzqtvg | Apr 18, 2017 | uhm{opp |
100054097 | - | ₹7.52L | diridln | Sep 15, 2016 | ytnrkdy |
100047561 | - | ₹1Cr | cfcy{gd | Aug 02, 2016 | qnmykj{ |
100047243 | - | ₹1Cr | eqfk{yo | Aug 02, 2016 | gpzuwsu |
100042598 | - | ₹8.76L | epomlid | Jul 08, 2016 | vzoroqh |
100039361 | - | ₹30L | evh{dec | Jun 24, 2016 | hvwpodk |
100037904 | - | ₹7.91L | s{iqtuv | Jun 24, 2016 | hjmqovs |
10623443 | - | ₹7.22L | ilsgckg | Dec 28, 2015 | tstkpmx |
10593303 | - | ₹10.6L | atkjwv{ | Aug 19, 2015 | nrxccyp |
To access detailed information on a company’s loans, borrowings, & registered charges, Buy Detailed Report
Credit Ratings of AGLOWMED LIMITED
GSTIN Details of AGLOWMED LIMITED
Board of Directors and Signatories of AGLOWMED LIMITED
Board of Directors of AGLOWMED LIMITED
Here is the list of current board of directors of AGLOWMED LIMITED:
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Managing Director | Current | Aug 25, 2003 | 22 Years 10 Months | |
Additional Director | Current | Sep 03, 2024 | 1 Year 10 Months | |
Additional Director | Current | Sep 11, 2024 | 1 Year 10 Months | |
Director | Current | Sep 10, 2004 | 21 Years 10 Months | |
Director | Current | Sep 09, 2009 | 16 Years 10 Months | |
Director | Current | Sep 30, 2017 | 8 Years 9 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Signatories of AGLOWMED LIMITED
Here is the list of current signatories of AGLOWMED LIMITED:
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Managing Director | Current | Aug 25, 2003 | 22 Years 10 Months | |
Director | Current | Sep 10, 2004 | 21 Years 10 Months | |
Director | Current | Sep 09, 2009 | 16 Years 10 Months | |
Director | Current | Sep 30, 2017 | 8 Years 9 Months | |
Additional Director | Current | Sep 03, 2024 | 1 Year 10 Months | |
Additional Director | Current | Sep 11, 2024 | 1 Year 10 Months |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Cross Directorships of AGLOWMED LIMITED
AGLOWMED LIMITED has directors who also hold positions in 13 other legal entities. All are listed below:
Legal Entity Name | % of Common Directors | Common Director(s) | Open Charge(s) | Active Legal Case(s) |
|---|---|---|---|---|
CURA FARMA PRIVATE LIMITED CIN: U00304BR2006PTC012268, India, Active | 157 | 689 | 282 | 409 |
SOTER PROPKEM PVT LTD CIN: U00500BR1985PTC002247, India, Active | 314 | 618 | 549 | 354 |
KUNAL PROPKEM PRIVATE LIMITED CIN: U24230BR1983PTC001749, India, Active | 770 | 101 | 916 | 170 |
AGLOCURE LABS PRIVATE LIMITED CIN: U24233MH2011PTC223329, India, Active | 326 | 677 | 739 | 760 |
AGLOW IMPEX PRIVATE LIMITED CIN: U51900MH1995PTC089778, India, Active | 117 | 322 | 583 | 782 |
VINDHYA BASINI ENTERPRISES PRIVATE LIMITED CIN: U15420BR2009PTC014549, India, Active | 722 | 658 | 707 | 734 |
INDO AMERICAN INNOVATIVE TECHNOLOGIES PRIVATE LIMITED CIN: U74996DL2006PTC155654, India, Active | 733 | 545 | 397 | 468 |
SEZ DEVELOPERS ASSOCIATION OF INDIA CIN: U45201MH2006NPL162985, India, Active | 614 | 826 | 172 | 520 |
INDO-ANGOLA CHAMBER OF COMMERCE AND INDUSTRY CIN: U91110MH2003NPL139578, India, Active | 583 | 778 | 408 | 341 |
ACINTA PHARMACEUTICALS PRIVATE LIMITED CIN: U24233MH2010PTC201377, India, Active | 740 | 312 | 754 | 120 |
JAIPUR GEMSTONE EXCHANGE CIN: U51390MH1990NPL055795, India, Active | 297 | 903 | 810 | 980 |
SURAT HIRA BOURSE CIN: U51398MH1989NPL053970, India, Active | 139 | 797 | 793 | 698 |
ANGOLA DIAMOND PRIVATE LIMITED CIN: U27205MH2001PTC134104, India, Active | 452 | 768 | 990 | 191 |
To access detailed information on a company’s board members, directors, & authorized signatories, Buy Detailed Report
Legal Cases involving AGLOWMED LIMITED
Employee Count of AGLOWMED LIMITED
AGLOWMED LIMITED has an employee count of 21 as on Aug 01, 2025.
Date | Employee Count |
|---|---|
Aug 25 | 21 |
Jul 25 | 903 |
Jun 25 | 275 |
May 25 | 363 |
Apr 25 | 778 |
Mar 25 | 629 |
Feb 25 | 499 |
Trademarks of AGLOWMED LIMITED
Patents of AGLOWMED LIMITED
FAQs about AGLOWMED LIMITED
Explore our recently published Legal Entities
